Advances in Synthesis of Piperazine Analogues and Molecular Targets: Unlocking Their Potential in CNS Disorder Therapy

View at publisher Summarise with VIRAT
Authors: Nishu Pal, Rajnish Kumar, Shrishti Tripathi, Avijit Mazumder, Salahuddin Salahuddin
Cited by: 0
References: 99

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

According to the World Health Organization's (WHO) Regional Committee for Europe's 2013 European Mental Health Action Plan, Central nervous system disorders and mental illnesses are among the biggest public health concerns in terms of prevalence, burden of disease, and disability. The types of psychological disorders include anxiety, epilepsy, Parkinson’s disease, depression, schizophrenia, etc. The etiology of mental diseases is significantly influenced by disruptions in the equilibrium between neurotransmitters, primarily serotonin (5-HT), dopamine (DA), and noradrenaline (NA), as a result of advances in our understanding of brain processes. Multi-receptor ligands are synthesized as antipsychotic drugs that could play multiple roles in different mental illnesses. These ligands utilize a multiple-ligand strategy between serotonin (5-HT1A and 5-HT2A) and dopamine (D2) receptors to imply their pharmacological action. Piperazine derivatives are a significant class of bioactive substances, especially when it comes to treating mental health issues. These compounds are useful in the treatment of anxiety, depression, schizophrenia, and other CNS disorders because they can interact with a range of neurotransmitter systems. In this review, we have underlined the synthetic methods for piperazine and its derivatives, which include coupling reactions, Gabriel synthesis, catalytic synthesis, etc. This work also enumerated the molecular targets, which have been reported to be responsible for the biological activities of piperzines. Furthermore, this work also paves the way for further research, formulation, and development of more useful molecules.

Fields of Study & Subjects

Heterocyclic Compound Synthesis and Bioactivity Synthesis and Characterization of Heterocyclic Compounds Chemical synthesis and pharmacological studies

Publication details

Journal / source
Letters in Organic Chemistry
Volume
23
Issue
7
Pages
449–477
Publication date
20 March 2026
Language
EN